Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 399


Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype.

Dong X, Lin Q, Aihara A, Li Y, Huang CK, Chung W, Tang Q, Chen X, Carlson R, Nadolny C, Gabriel G, Olsen M, Wands JR.

Oncotarget. 2019 Nov 12;10(61):6644-6646. doi: 10.18632/oncotarget.27315. eCollection 2019 Nov 12.


A Novel Drug, CC-122, Inhibits Tumor Growth in Hepatocellular Carcinoma through Downregulation of an Oncogenic TCF-4 Isoform.

Tomimaru Y, Aihara A, Wands JR, Aloman C, Kim M.

Transl Oncol. 2019 Oct;12(10):1345-1356. doi: 10.1016/j.tranon.2019.07.002. Epub 2019 Jul 25.


Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma.

Nagaoka K, Bai X, Ogawa K, Dong X, Zhang S, Zhou Y, Carlson RI, Jiang ZG, Fuller S, Lebowitz MS, Ghanbari H, Wands JR.

Cancer Lett. 2019 May 1;449:87-98. doi: 10.1016/j.canlet.2019.02.006. Epub 2019 Feb 12.


Comprehensive molecular and immunological characterization of hepatocellular carcinoma.

Shimada S, Mogushi K, Akiyama Y, Furuyama T, Watanabe S, Ogura T, Ogawa K, Ono H, Mitsunori Y, Ban D, Kudo A, Arii S, Tanabe M, Wands JR, Tanaka S.

EBioMedicine. 2019 Feb;40:457-470. doi: 10.1016/j.ebiom.2018.12.058. Epub 2018 Dec 29.


Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.

Ji C, Nagaoka K, Zou J, Casulli S, Lu S, Cao KY, Zhang H, Iwagami Y, Carlson RI, Brooks K, Lawrence J, Mueller W, Wands JR, Huang CK.

FASEB J. 2019 Feb;33(2):1824-1835. doi: 10.1096/fj.201800736R. Epub 2018 Sep 6.


Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation.

Huang CK, Iwagami Y, Zou J, Casulli S, Lu S, Nagaoka K, Ji C, Ogawa K, Cao KY, Gao JS, Carlson RI, Wands JR.

Cancer Lett. 2018 Aug 10;429:1-10. doi: 10.1016/j.canlet.2018.04.041. Epub 2018 May 5.


Endocrine sensitivity of estrogen receptor-positive breast cancer is negatively correlated with aspartate-β-hydroxylase expression.

Shimoda M, Hori A, Wands JR, Tsunashima R, Naoi Y, Miyake T, Tanei T, Kagara N, Shimazu K, Kim SJ, Noguchi S.

Cancer Sci. 2017 Dec;108(12):2454-2461. doi: 10.1111/cas.13416. Epub 2017 Oct 21.


Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma.

Iwagami Y, Casulli S, Nagaoka K, Kim M, Carlson RI, Ogawa K, Lebowitz MS, Fuller S, Biswas B, Stewart S, Dong X, Ghanbari H, Wands JR.

Heliyon. 2017 Sep 26;3(9):e00407. doi: 10.1016/j.heliyon.2017.e00407. eCollection 2017 Sep.


Differential regulation of hepatitis B virus core protein expression and genome replication by a small upstream open reading frame and naturally occurring mutations in the precore region.

Zong L, Qin Y, Jia H, Ye L, Wang Y, Zhang J, Wands JR, Tong S, Li J.

Virology. 2017 May;505:155-161. doi: 10.1016/j.virol.2017.02.020. Epub 2017 Mar 3.


Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPase.

Shapiro JM, Chung W, Ogawa K, Barker L, Carlson R, Wands JR, Li J.

PLoS One. 2016 Nov 1;11(11):e0165227. doi: 10.1371/journal.pone.0165227. eCollection 2016.


NFIL3 Expression Distinguishes Tissue-Resident NK Cells and Conventional NK-like Cells in the Mouse Submandibular Glands.

Erick TK, Anderson CK, Reilly EC, Wands JR, Brossay L.

J Immunol. 2016 Sep 15;197(6):2485-91. doi: 10.4049/jimmunol.1601099. Epub 2016 Aug 12.


Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.

Li J, Zong L, Sureau C, Barker L, Wands JR, Tong S.

J Virol. 2016 Aug 26;90(18):8302-13. doi: 10.1128/JVI.01153-16. Print 2016 Sep 15.


Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.

Huang CK, Aihara A, Iwagami Y, Yu T, Carlson R, Koga H, Kim M, Zou J, Casulli S, Wands JR.

Cancer Lett. 2016 Sep 28;380(1):153-62. doi: 10.1016/j.canlet.2016.05.038. Epub 2016 Jun 27.


Molecular pathology of advanced hepatocellular carcinoma.

Aihara A, Wands JR, Tanaka S.

Nihon Shokakibyo Gakkai Zasshi. 2016 May;113(5):790-7. doi: 10.11405/nisshoshi.113.790. Japanese. No abstract available.


Corrigendum: X-ray Scatter Imaging of Hepatocellular Carcinoma in a Mouse Model Using Nanoparticle Contrast Agents.

Rand D, Derdak Z, Carlson R, Wands JR, Rose-Petruck C.

Sci Rep. 2016 Mar 10;6:21229. doi: 10.1038/srep21229. No abstract available.


Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.

Iwagami Y, Huang CK, Olsen MJ, Thomas JM, Jang G, Kim M, Lin Q, Carlson RI, Wagner CE, Dong X, Wands JR.

Hepatology. 2016 Apr;63(4):1213-26. doi: 10.1002/hep.28411. Epub 2016 Feb 19.


X-ray Scatter Imaging of Hepatocellular Carcinoma in a Mouse Model Using Nanoparticle Contrast Agents.

Rand D, Derdak Z, Carlson R, Wands JR, Rose-Petruck C.

Sci Rep. 2015 Oct 29;5:15673. doi: 10.1038/srep15673. Erratum in: Sci Rep. 2016;6:21229.


Activation of signal transduction pathways during hepatic oncogenesis.

Chung W, Kim M, de la Monte S, Longato L, Carlson R, Slagle BL, Dong X, Wands JR.

Cancer Lett. 2016 Jan 1;370(1):1-9. doi: 10.1016/j.canlet.2015.09.016. Epub 2015 Oct 1.


Restoration of Wnt/β-catenin signaling attenuates alcoholic liver disease progression in a rat model.

Huang CK, Yu T, de la Monte SM, Wands JR, Derdak Z, Kim M.

J Hepatol. 2015 Jul;63(1):191-8. doi: 10.1016/j.jhep.2015.02.030. Epub 2015 Feb 24.


Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.

Tomimaru Y, Mishra S, Safran H, Charpentier KP, Martin W, De Groot AS, Gregory SH, Wands JR.

Vaccine. 2015 Mar 3;33(10):1256-66. doi: 10.1016/j.vaccine.2015.01.037. Epub 2015 Jan 25.


A highly sensitive x-ray imaging modality for hepatocellular carcinoma detection in vitro.

Rand D, Walsh EG, Derdak Z, Wands JR, Rose-Petruck C.

Phys Med Biol. 2015 Jan 21;60(2):769-84. doi: 10.1088/0031-9155/60/2/769. Epub 2015 Jan 5.


Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype.

Dong X, Lin Q, Aihara A, Li Y, Huang CK, Chung W, Tang Q, Chen X, Carlson R, Nadolny C, Gabriel G, Olsen M, Wands JR.

Oncotarget. 2015 Jan 20;6(2):1231-48. Erratum in: Oncotarget. 2019 Nov 12;10(61):6644-6646.


A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma.

Aihara A, Huang CK, Olsen MJ, Lin Q, Chung W, Tang Q, Dong X, Wands JR.

Hepatology. 2014 Oct;60(4):1302-13. doi: 10.1002/hep.27275. Epub 2014 Aug 25.


LRH1 promotes pancreatic cancer metastasis.

Lin Q, Aihara A, Chung W, Li Y, Chen X, Huang Z, Weng S, Carlson RI, Nadolny C, Wands JR, Dong X.

Cancer Lett. 2014 Aug 1;350(1-2):15-24. doi: 10.1016/j.canlet.2014.04.017. Epub 2014 Apr 24.


WNT/β-catenin signaling and hepatocellular carcinoma.

Wands JR, Kim M.

Hepatology. 2014 Aug;60(2):452-4. doi: 10.1002/hep.27081. Epub 2014 Jun 18. No abstract available.


Strain-dependent differences for suppression of insulin-stimulated glucose uptake in skeletal and cardiac muscle by ethanol.

Lang CH, Derdak Z, Wands JR.

Alcohol Clin Exp Res. 2014 Apr;38(4):897-910. doi: 10.1111/acer.12343. Epub 2014 Jan 24.


Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.

Tong M, Longato L, Ramirez T, Zabala V, Wands JR, de la Monte SM.

Int J Exp Pathol. 2014 Feb;95(1):49-63. doi: 10.1111/iep.12052. Epub 2013 Oct 29.


LRH1 as a driving factor in pancreatic cancer growth.

Lin Q, Aihara A, Chung W, Li Y, Huang Z, Chen X, Weng S, Carlson RI, Wands JR, Dong X.

Cancer Lett. 2014 Apr 1;345(1):85-90. doi: 10.1016/j.canlet.2013.11.014. Epub 2013 Dec 11.


Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.

Pez F, Lopez A, Kim M, Wands JR, Caron de Fromentel C, Merle P.

J Hepatol. 2013 Nov;59(5):1107-17. doi: 10.1016/j.jhep.2013.07.001. Epub 2013 Jul 5. Review.


Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma.

Tomimaru Y, Koga H, Yano H, de la Monte S, Wands JR, Kim M.

Liver Int. 2013 Aug;33(7):1100-12. doi: 10.1111/liv.12188. Epub 2013 May 8.


Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity.

Tomimaru Y, Xu CQ, Nambotin SB, Yan T, Wands JR, Kim M.

Liver Int. 2013 Nov;33(10):1536-48. doi: 10.1111/liv.12189. Epub 2013 May 6.


The SxxSS motif of T-cell factor-4 isoforms modulates Wnt/β-catenin signal activation in hepatocellular carcinoma cells.

Tomimaru Y, Koga H, Shin TH, Xu CQ, Wands JR, Kim M.

Cancer Lett. 2013 Aug 19;336(2):359-69. doi: 10.1016/j.canlet.2013.03.031. Epub 2013 Apr 2.


Hepatitis B virus genetic variants: biological properties and clinical implications.

Tong S, Li J, Wands JR, Wen YM.

Emerg Microbes Infect. 2013 Mar;2(3):e10. doi: 10.1038/emi.2013.10. Epub 2013 Mar 13. Review.


Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.

Derdak Z, Villegas KA, Harb R, Wu AM, Sousa A, Wands JR.

J Hepatol. 2013 Apr;58(4):785-91. doi: 10.1016/j.jhep.2012.11.042. Epub 2012 Dec 2.


Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis.

Ramirez T, Longato L, Dostalek M, Tong M, Wands JR, de la Monte SM.

Alcohol Alcohol. 2013 Jan-Feb;48(1):39-52. doi: 10.1093/alcalc/ags106. Epub 2012 Sep 20.


Chronic alcohol-induced hepatic insulin resistance and endoplasmic reticulum stress ameliorated by peroxisome-proliferator activated receptor-δ agonist treatment.

Ramirez T, Tong M, Chen WC, Nguyen QG, Wands JR, de la Monte SM.

J Gastroenterol Hepatol. 2013 Jan;28(1):179-87. doi: 10.1111/j.1440-1746.2012.07256.x.


Loss of the SxxSS motif in a human T-cell factor-4 isoform confers hypoxia resistance to liver cancer: an oncogenic switch in Wnt signaling.

Koga H, Tsedensodnom O, Tomimaru Y, Walker EJ, Lee HC, Kim KM, Yano H, Wands JR, Kim M.

PLoS One. 2012;7(6):e39981. doi: 10.1371/journal.pone.0039981. Epub 2012 Jun 29.


Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection.

Reilly EC, Thompson EA, Aspeslagh S, Wands JR, Elewaut D, Brossay L.

PLoS One. 2012;7(5):e37991. doi: 10.1371/journal.pone.0037991. Epub 2012 May 23.


Structural Correlates of PPAR Agonist Rescue of Experimental Chronic Alcohol-Induced Steatohepatitis.

Ramirez T, Tong M, Ayala CA, Monfils PR, McMillan PN, Zabala V, Wands JR, de la Monte SM.

J Clin Exp Pathol. 2012 Jun;2(4). pii: 114.


Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease.

Longato L, Ripp K, Setshedi M, Dostalek M, Akhlaghi F, Branda M, Wands JR, de la Monte SM.

Oxid Med Cell Longev. 2012;2012:479348. doi: 10.1155/2012/479348. Epub 2012 Apr 22.


Alcohol, insulin resistance and the liver-brain axis.

de la Monte S, Derdak Z, Wands JR.

J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:33-41. doi: 10.1111/j.1440-1746.2011.07023.x. Review.


Early growth response-1 transcription factor promotes hepatic fibrosis and steatosis in long-term ethanol-fed Long-Evans rats.

Derdak Z, Villegas KA, Wands JR.

Liver Int. 2012 May;32(5):761-70. doi: 10.1111/j.1478-3231.2012.02752.x. Epub 2012 Jan 31.


Functional consequences of WNT3/Frizzled7-mediated signaling in non-transformed hepatic cells.

Nambotin SB, Tomimaru Y, Merle P, Wands JR, Kim M.

Oncogenesis. 2012 Oct 22;1:e31. doi: 10.1038/oncsis.2012.31.


High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism.

Longato L, Tong M, Wands JR, de la Monte SM.

Hepatol Res. 2012 Apr;42(4):412-27. doi: 10.1111/j.1872-034X.2011.00934.x. Epub 2011 Dec 16.


Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma.

Walker EJ, Rosenberg SA, Wands JR, Kim M.

For Immunopathol Dis Therap. 2011;2(2):195-204.


Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.

Noda T, Shimoda M, Ortiz V, Sirica AE, Wands JR.

Hepatology. 2012 Jan;55(1):86-97. doi: 10.1002/hep.24629.


Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels.

Promrat K, Longato L, Wands JR, de la Monte SM.

Hepatol Res. 2011 Aug;41(8):754-62. doi: 10.1111/j.1872-034X.2011.00815.x.


Limited therapeutic effect of N-acetylcysteine on hepatic insulin resistance in an experimental model of alcohol-induced steatohepatitis.

Setshedi M, Longato L, Petersen DR, Ronis M, Chen WC, Wands JR, de la Monte SM.

Alcohol Clin Exp Res. 2011 Dec;35(12):2139-51. doi: 10.1111/j.1530-0277.2011.01569.x. Epub 2011 Jul 25.

Supplemental Content

Loading ...
Support Center